Cancer Research Annual Meeting 2010  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 42, 465-472, February 1, 1982]
© 1982 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Campbell, H. A.
Right arrow Articles by Laishes, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Campbell, H. A.
Right arrow Articles by Laishes, B. A.

Application of Quantitative Stereology to the Evaluation of Enzymealtered Foci in Rat Liver1

H. A. Campbell, H. C. Pitot2, Van R. Potter and B. A. Laishes

McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, Wisconsin 53706

The mathematical science of quantitative stereology has established relationships for the quantitation of elements in three-dimensional space from observations on two-dimensional planes. This report describes the utilization and importance of such mathematical relationships for the quantitative analysis of focal hepatic lesions in terms relative to the volume of the liver.

Three examples are utilized to demonstrate the utility of such calculations in the three-dimensional quantitation of hepatic focal lesions. The first is that of a computer-simulated experiment based on defined hypothetical situations. The simulations demonstrate the applicability of the computations described in this report to the evaluation of two-dimensional data from typical animal experiments. The other two examples are taken from actual experiments and involve the transplantation of hepatic cell populations into the liver of suitably prepared hosts and the quantitation of altered foci produced by initiation with diethylnitrosamine-partial hepatectomy followed by promotion with phenobarbital. The quantitation of altered foci by means of a two-dimensional analysis (simple enumeration of focal intersections/area of tissue section) is proportional to the quantitation of foci per volume of liver provided that the mean diameter of the foci for each treatment is sufficiently uniform, as exemplified in the text by the transplantation experiment. When such mean diameters are unequal as in the diethylnitrosamine-phenobarbital experiment described herein, quantitation from three-dimensional analysis gives significantly different results as compared with enumeration of focal intersections on two-dimensional areas. These studies clearly demonstrate that the frequency and size of foci intersections viewed on two-dimensional tissue sections do not necessarily reflect the number or size of foci in the three-dimensional tissue. Only by quantitating the number and size of the foci in relation to the three-dimensional volume of the tissue can one determine the validity of the proportionality of data from two-dimensional measurements to the total number of foci per volume of tissue. Such a conclusion has important implications for quantitative studies on hepatocarcinogenesis as well as for the enumeration of premalignant lesions which occur during the natural history of carcinogenesis in any solid tissue.

1 The studies reported herein were supported in part by CA-07175, CA-22484, CA-24818, and CA-17334 from the National Cancer Institute.

2 To whom requests for reprints should be addressed.

Received 7/13/81. Accepted 10/27/81.




This article has been cited by other articles:


Home page
Jpn J Clin OncolHome page
K. Satoh, D. Yamakawa, H. Sugio, K. Kida, T. Sato, K. Hosoi, and M. Hayakari
Bile Duct-bound Growth of Precursor Cells of Preneoplastic Foci Inducible in the Initiation Stage of Rat Chemical Hepatocarcinogenesis by 2-Acetylaminofluorene
Jpn. J. Clin. Oncol., September 1, 2008; 38(9): 604 - 610.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
P. Marx-Stoelting, J. Mahr, T. Knorpp, S. Schreiber, M. F. Templin, T. Ott, A. Buchmann, and M. Schwarz
Tumor Promotion in Liver of Mice with a Conditional Cx26 Knockout
Toxicol. Sci., June 1, 2008; 103(2): 260 - 267.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
D. N. Stemm, J. C. Tharappel, H.-J. Lehmler, C. Srinivasan, J. S. Morris, V. L. Spate, L. W. Robertson, B. T. Spear, and H. P. Glauert
Effect of Dietary Selenium on the Promotion of Hepatocarcinogenesis by 3,3', 4,4'-Tetrachlorobiphenyl and 2,2', 4,4', 5,5'-Hexachlorobiphenyl
Experimental Biology and Medicine, March 1, 2008; 233(3): 366 - 376.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
H. P. Glauert, Z. Lu, A. Kumar, R. P. Bunaciu, S. Patel, J. C. Tharappel, D. N. Stemm, H.-J. Lehmler, E. Y. Lee, L. W. Robertson, et al.
Dietary Vitamin E Does Not Inhibit the Promotion of Liver Carcinogenesis by Polychlorinated Biphenyls in Rats
J. Nutr., February 1, 2005; 135(2): 283 - 286.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
P. Espandiari, H. P. Glauert, H.-J. Lehmler, E. Y. Lee, C. Srinivasan, and L. W. Robertson
Initiating Activity of 4-Chlorobiphenyl Metabolites in the Resistant Hepatocyte Model
Toxicol. Sci., May 1, 2004; 79(1): 41 - 46.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Nakaji, Y. Yano, T. Ninomiya, Y. Seo, K. Hamano, S. Yoon, M. Kasuga, T. Teramoto, Y. Hayashi, and H. Yokozaki
IFN-alpha prevents the growth of pre-neoplastic lesions and inhibits the development of hepatocellular carcinoma in the rat
Carcinogenesis, March 1, 2004; 25(3): 389 - 397.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Satoh and I. Hatayama
Anomalous elevation of glutathione S-transferase P-form (GST-P) in the elementary process of epigenetic initiation of chemical hepatocarcinogenesis in rats
Carcinogenesis, July 1, 2002; 23(7): 1193 - 1198.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Maruyama, N. Nagasue, D. K. Dhar, A. Yamanoi, O. N. El-Assal, K. Satoh, and K. Okita
Preventive Effect of FK143, a 5{{alpha}}-Reductase Inhibitor, on Chemical Hepatocarcinogenesis in Rats
Clin. Cancer Res., July 1, 2001; 7(7): 2096 - 2104.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
O. Moennikes, A. Buchmann, A. Romualdi, T. Ott, J. Werringloer, K. Willecke, and M. Schwarz
Lack of Phenobarbital-mediated Promotion of Hepatocarcinogenesis in Connexin32-Null Mice
Cancer Res., September 1, 2000; 60(18): 5087 - 5091.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
B. Grasl-Kraupp, G. Luebeck, A. Wagner, A. Low-Baselli, M. de Gunst, T. Waldhor, S. Moolgavkar, and R. Schulte-Hermann
Quantitative analysis of tumor initiation in rat liver: role of cell replication and cell death (apoptosis)
Carcinogenesis, July 1, 2000; 21(7): 1411 - 1421.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
N. J. Walker, A. M. Tritscher, R. C. Sills, G. W. Lucier, and C. J. Portier
Hepatocarcinogenesis in Female Sprague-Dawley Rats following Discontinuous Treatment with 2,3,7,8-Tetrachlorodibenzo-p-dioxin
Toxicol. Sci., April 1, 2000; 54(2): 330 - 337.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
X. Lin, D. A. Levitsky, J. M. King, and T. C. Campbell
The promotion effect of anorectic drugs on aflatoxin B1-induced hepatic preneoplastic foci
Carcinogenesis, September 1, 1999; 20(9): 1793 - 1799.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
O. Moennikes, A. Buchmann, T. Ott, K. Willecke1, and M. Schwarz2
The effect of connexin32 null mutation on hepatocarcinogenesis in different mouse strains
Carcinogenesis, July 1, 1999; 20(7): 1379 - 1382.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
R. C. Sills, T. L. Goldsworthy, and S. D. Sleight
Tumor-Promoting Effects of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin and Phenobarbital in Initiated Weanling Sprague-Dawley Rats: A Quantitative, Phenotypic, and ras p21 Protein Study
Toxicol Pathol, May 1, 1994; 22(3): 270 - 281.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
H. Maruyama, T. Tanaka, and G. M. Williams
Effects of the Peroxisome Proliferator Di(2-Ethylhexyl)Phthalate on Enzymes in Rat Liver and on Carcinogen-Induced Liver Altered Foci in Comparison to the Promoter Phenobarbital
Toxicol Pathol, February 1, 1990; 18(2): 257 - 267.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
B. R. Broxup, V. E. O. Valli, G. L. Losos, D. H. Percy, E. Farber, and I. Mcmillan
Morphometric Evaluation of Hepatocellular Proliferative Lesions in the Rat Liver
Toxicol Pathol, June 1, 1988; 16(4): 401 - 417.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
T. Kitagawa
Promoting and Anticarcinogenic Effects of Phenobarbital and DDT in the Rat Hepatocarcinogenesis
Toxicol Pathol, April 1, 1986; 14(3): 309 - 314.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
G. Malvaldi, E. Chieli, and M. Saviozzi
Characterization of the Promoting Activity of Thiobenzamide on Liver Carcinogenesis
Toxicol Pathol, April 1, 1986; 14(3): 370 - 374.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
K. C. Cater, A. J. Gandolfi, and I. G. Sipes
Characterization of Dimethylnitrosamineinduced Focal and Nodular Lesions in the Livers of Newborn Mice
Toxicol Pathol, January 1, 1985; 13(1): 3 - 9.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
J. A. Popp and T. B. Leonard
The Use of In vivo Hepatic Initiation-Promotion Systems in Understanding the Hepatocarcinogenesis of Technical Grade Dinitrotoluene
Toxicol Pathol, February 1, 1982; 10(2): 190 - 194.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1982 by the American Association for Cancer Research.